Our Executive Team

Led by President Jerzy Gruhn, our nine-member executive team manages our U.S. business. Each of these vastly-experienced professionals leads a specific area of the business, monitoring our progress according to Novo Nordisk's Triple Bottom Line: building our business in a way that is financially profitable while being socially responsible and environmentally sound. The executive team has the diversity of skills, sense of purpose, and strategic vision to guide our company to consistently higher levels of success. Their combined strengths serve to cement our position as a leader in diabetes care and accelerate the growth of our biopharmaceuticals unit. 

Jerzy Gruhn
President, Novo Nordisk Inc.

Phil Fornecker
Vice President, Strategic Business Operations

Jeff Frazier
Vice President, Human Resources

Pamela Harris
Vice President, Diabetes Sales, Managed Care & Government Accounts

Camille Lee
Vice President, Diabetes Brand Marketing

Andrew Purcell
Vice President, Strategic Business Development

Henrik Rasmussen, M.D., Ph.D.
Vice President, Clinical Development, Medical & Regulatory Affairs

Jim Shehan
Vice President, Legal, Government & Quality Affairs

Edward Williams
Vice President, Biopharmaceuticals